Trial Management STREAM

51. Navigating Early Phase CNS-Active Drug Development 2/14/2023

    Early development of CNS-active drugs requires in-depth clinical expertise. Altasciences’ Dr. Beatrice Setnik, Chief Scientific Officer, examines the strategies to ensure early comprehensive data collection to fulfill regulatory requirements and aid in evaluating the risk/benefit profile.

52. At The Crossroads Of Data: eCOA And Sensors Converging For Novel Insights 5/20/2025

    Leveraging sensors and eCOA addresses increasing clinical trial complexity and ensures a more efficient and effective study design.

53. Clinical Trials And TMF 101 Learning Series: 1st Session 9/20/2022

    Spark a deeper and broader understanding of the world of Drug Development, Clinical Trials, Regulations, the Trial Master File, and much more – for the industry novice as well as the guru.

54. Take A Look Inside The Pharmacodynamic Toolbox 1/30/2023

    This session explores the flexible selection of pharmacodynamic measures to enhance the pharmacology, safety, and efficacy evaluation of a CNS-active drug in early clinical trials.

55. How Sample Issues Can Cause Bioequivalence Studies To Fail 7/17/2026

    In this webinar excerpt, we learn why biological sample issues can have such an outsized impact in bioequivalence studies.

56. Korio RTSM Platform: Real-Time Audit Trail Demo 3/18/2026

    Watch a real-time walkthrough of Korio’s built-in audit trail. Human-readable, blind-controlled, and fully exportable—see how sponsors get instant access to critical trial data.

57. Lack Of IRT/RTSM System Reusability Surprises Every Clinical Trial Sponsor 2/26/2026

    Stop re-learning your IRT system with every new trial. Uncover why "standard" features often hide custom complexities that slow down UAT and clinical operations.

58. Think U.S.A.: The Operations Behind Your Clinical Trials 1/22/2025

    Ready to think differently about early-phase clinical development? Check out the spotlight on our U.S. clinical facilities and the incredible teams behind them.

59. Disclosure As A Service ROI 6/3/2020

    How do sponsors determine the ROI of Disclosure as a Service? TrialScope talks with two sponsors – a large pharmaceutical company and a smaller biotech – for their take on this. Watch the short video.

60. Solving The Impossible In Glioblastoma With An AI Synthetic Control Arm 9/9/2022

    This video discusses Medicenna’s MDNA55-05 clinical trial; a single-arm, open-label, multicenter study that offers a promising opportunity to improve outcomes for recurrent glioblastoma.